Supply of monoclonal antibody treatment, one of the most effective therapies for symptomatic COVID-19 patients, is now severely limited as outbreaks in mostly southern states with low vaccination rates drive a surge in demand. “On a national level, it’s been devastating,” said Family Health Centers of San Diego infectious disease specialist Dr. Christian Ramers. “In my own clinic, we now…